• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光谱研究抗癌前药顺式,顺式,顺式-[Pt(NH3)2(OH)(py)]的光诱导反应。

Spectroscopic Studies on Photoinduced Reactions of the Anticancer Prodrug, trans,trans,trans-[Pt(N ) (OH) (py) ].

机构信息

School of Chemistry and Centre for Biospectroscopy, Monash University, Clayton, 3800, VIC, Australia.

Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK.

出版信息

Chemistry. 2018 Apr 17;24(22):5790-5803. doi: 10.1002/chem.201705349. Epub 2018 Feb 5.

DOI:10.1002/chem.201705349
PMID:29314368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5947305/
Abstract

The photodecomposition mechanism of trans,trans,trans-[Pt(N ) (OH) (py) ] (1, py=pyridine), an anticancer prodrug candidate, was probed using complementary Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR), transient electronic absorption, and UV/Vis spectroscopy. Data fitting using Principal Component Analysis (PCA) and Multi-Curve Resolution Alternating Least Squares, suggests the formation of a trans-[Pt(N )(py) (OH/H O)] intermediate and trans-[Pt(py) (OH/H O) ] as the final product upon 420 nm irradiation of 1 in water. Rapid disappearance of the hydroxido ligand stretching vibration upon irradiation is correlated with a -10 cm shift to the antisymmetric azido vibration, suggesting a possible second intermediate. Experimental proof of subsequent dissociation of azido ligands from platinum is presented, in which at least one hydroxyl radical is formed in the reduction of Pt to Pt . Additionally, the photoinduced reaction of 1 with the nucleotide 5'-guanosine monophosphate (5'-GMP) was comprehensively studied, and the identity of key photoproducts was assigned with the help of ATR-FTIR spectroscopy, mass spectrometry, and density functional theory calculations. The identification of marker bands for some of these photoproducts (e.g., trans-[Pt(N )(py) (5'-GMP)] and trans-[Pt(py) (5'-GMP) ]) will aid elucidation of the chemical and biological mechanism of anticancer action of 1. In general, these studies demonstrate the potential of vibrational spectroscopic techniques as promising tools for studying such metal complexes.

摘要

反式,反式,反式-[Pt(N )(OH)(py)](1,py=吡啶),一种抗癌前药候选物的光分解机制,使用互补的衰减全反射傅里叶变换红外(ATR-FTIR),瞬态电子吸收和紫外/可见光谱进行了探测。使用主成分分析(PCA)和多曲线分辨率交替最小二乘法对数据进行拟合,表明在水照射 420nm 时,形成了反式-[Pt(N )(py)(OH/H O)]中间体和反式-[Pt(py)(OH/H O)]作为最终产物。照射后羟基数配体伸缩振动的快速消失与反式对称叠氮振动的-10cm 位移相关,表明可能存在第二个中间产物。实验证明了随后从铂中离解叠氮配体,其中至少有一个羟基自由基在将 Pt 还原为 Pt 时形成。此外,全面研究了 1 与核苷酸 5'-鸟苷一磷酸(5'-GMP)的光诱导反应,并借助 ATR-FTIR 光谱,质谱和密度泛函理论计算确定了关键光产物的身份。这些光产物(例如反式-[Pt(N )(py)(5'-GMP)]和反式-[Pt(py)(5'-GMP)])的一些标记带的鉴定将有助于阐明 1 的抗癌作用的化学和生物学机制。一般来说,这些研究表明振动光谱技术作为研究此类金属配合物的有前途的工具的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/4e449a96cf66/CHEM-24-5790-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/a3b031f99a1a/CHEM-24-5790-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/044a319fd189/CHEM-24-5790-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/85e1bc768ddf/CHEM-24-5790-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/7838bba52f8f/CHEM-24-5790-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/9900421dc1e1/CHEM-24-5790-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/73e142ab3e79/CHEM-24-5790-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/076b80e86922/CHEM-24-5790-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/7b796b467054/CHEM-24-5790-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/4e449a96cf66/CHEM-24-5790-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/a3b031f99a1a/CHEM-24-5790-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/044a319fd189/CHEM-24-5790-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/85e1bc768ddf/CHEM-24-5790-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/7838bba52f8f/CHEM-24-5790-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/9900421dc1e1/CHEM-24-5790-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/73e142ab3e79/CHEM-24-5790-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/076b80e86922/CHEM-24-5790-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/7b796b467054/CHEM-24-5790-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/5947305/4e449a96cf66/CHEM-24-5790-g009.jpg

相似文献

1
Spectroscopic Studies on Photoinduced Reactions of the Anticancer Prodrug, trans,trans,trans-[Pt(N ) (OH) (py) ].光谱研究抗癌前药顺式,顺式,顺式-[Pt(NH3)2(OH)(py)]的光诱导反应。
Chemistry. 2018 Apr 17;24(22):5790-5803. doi: 10.1002/chem.201705349. Epub 2018 Feb 5.
2
Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate.反式、反式、反式-[Pt(N₃)₂(OH)₂(py)₂]的综合振动光谱研究,一种铂(IV)二叠氮基抗癌前药候选物。
Inorg Chem. 2016 Jun 20;55(12):5983-92. doi: 10.1021/acs.inorgchem.6b00476. Epub 2016 Jun 3.
3
Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.光活化的细胞选择性双核反式叠氮基铂(IV)抗癌前药。
Inorg Chem. 2018 Nov 19;57(22):14409-14420. doi: 10.1021/acs.inorgchem.8b02599. Epub 2018 Oct 26.
4
Adenine-adenine, adenine-cytosine and cytosine-cytosine intrastrand crosslinks induced by a photoactivatable Pt(IV) anticancer prodrug.由光活化的 Pt(IV)抗癌前药诱导的腺嘌呤-腺嘌呤、腺嘌呤-胞嘧啶和胞嘧啶-胞嘧啶链内交联。
Dalton Trans. 2023 Dec 19;53(1):292-298. doi: 10.1039/d3dt03351a.
5
Probing platinum azido complexes by 14N and 15N NMR spectroscopy.通过 14N 和 15N NMR 光谱研究铂叠氮络合物。
Chemistry. 2011 Oct 17;17(43):12059-66. doi: 10.1002/chem.201101409. Epub 2011 Sep 16.
6
Reaction of human telomeric unit TTAGGG and a photoactivatable Pt(IV) anticancer prodrug.人端粒单元 TTAGGG 与光活化型铂(IV)抗癌前药的反应。
Dalton Trans. 2023 Aug 29;52(34):12057-12066. doi: 10.1039/d3dt01643a.
7
A computational approach to tuning the photochemistry of platinum(IV) anticancer agents.一种调谐顺铂类抗癌药物光化学性的计算方法。
Chemistry. 2012 Aug 20;18(34):10630-42. doi: 10.1002/chem.201200782. Epub 2012 Jul 13.
8
Preparation of ,-[Pt(py)(N)(OH)] via Photoinduced Reactivity of [Pt(NO)] Anion.通过[Pt(NO)]阴离子的光诱导反应制备,-[Pt(py)(N)(OH)] 。 (你提供的原文中存在一些不太明确的字符表述,可能会影响更准确理解,以上是按现有内容尽量准确翻译的结果)
Inorg Chem. 2025 Feb 10;64(5):2336-2347. doi: 10.1021/acs.inorgchem.4c04536. Epub 2025 Jan 28.
9
Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.叠氮基混合胺铂(IV)抗癌配合物可被可见光激活,形成新型 DNA 加合物。
Chemistry. 2013 Jul 15;19(29):9578-91. doi: 10.1002/chem.201300374. Epub 2013 Jun 3.
10
Reactions of a photoactivatable diazido Pt(iv) anticancer complex with a single-stranded oligodeoxynucleotide.光活化的叠氮基 Pt(iv) 抗癌配合物与单链寡脱氧核苷酸的反应。
Dalton Trans. 2020 Aug 18;49(32):11249-11259. doi: 10.1039/d0dt02208j.

引用本文的文献

1
Primary processes in photophysics and photochemistry of a potential light-activated anti-cancer dirhodium complex.潜在的光激活抗癌双铑配合物的光物理和光化学的初级过程。
Photochem Photobiol Sci. 2024 Jan;23(1):153-162. doi: 10.1007/s43630-023-00509-y. Epub 2023 Dec 8.
2
Monitoring and modelling the dynamics of the cellular glycolysis pathway: A review and future perspectives.监测和建模细胞糖酵解途径的动力学:综述与未来展望。
Mol Metab. 2022 Dec;66:101635. doi: 10.1016/j.molmet.2022.101635. Epub 2022 Nov 12.
3
DFT Study on the Substituent Effect of Anticancer Picoline-Diazido-Pt(IV) Compounds.

本文引用的文献

1
Green light-induced apoptosis in cancer cells by a tetrapyridyl ruthenium prodrug offering two coordination sites.一种具有两个配位位点的四吡啶钌前药通过绿光诱导癌细胞凋亡。
Chem Sci. 2016 Aug 1;7(8):4922-4929. doi: 10.1039/c6sc00167j. Epub 2016 Apr 25.
2
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.钌(II)配合物与光的联合:癌症治疗的新前沿
Chem Sci. 2015 May 1;6(5):2660-2686. doi: 10.1039/c4sc03759f. Epub 2015 Jan 13.
3
Primary photochemical processes for Pt(iv) diazido complexes prospective in photodynamic therapy of tumors.
抗癌吡啶二叠氮铂(IV)化合物取代基效应的密度泛函理论研究
Front Oncol. 2022 Jan 10;11:749178. doi: 10.3389/fonc.2021.749178. eCollection 2021.
4
Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes.光活化铂类抗癌配合物的单细胞化学
J Am Chem Soc. 2021 Dec 8;143(48):20224-20240. doi: 10.1021/jacs.1c08630. Epub 2021 Nov 22.
5
The Role of Norrish Type-I Chemistry in Photoactive Drugs: An Study of a Cyclopropenone-Enediyne Drug Precursor.Norrish I型化学在光活性药物中的作用:环丙烯酮-烯二炔药物前体的研究
Front Chem. 2020 Dec 22;8:596590. doi: 10.3389/fchem.2020.596590. eCollection 2020.
6
Label Free Raman Microspectroscopic Analysis to Monitor the Uptake, Fate and Impacts of Nanoparticle Based Materials.基于纳米颗粒材料的摄取、命运及影响监测的无标记拉曼显微光谱分析
Front Bioeng Biotechnol. 2020 Oct 29;8:544311. doi: 10.3389/fbioe.2020.544311. eCollection 2020.
7
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent.砷铂-1 是一种双药效团抗癌药物。
J Am Chem Soc. 2019 Apr 24;141(16):6453-6457. doi: 10.1021/jacs.8b13681. Epub 2019 Apr 15.
用于肿瘤光动力治疗的 Pt(iv)叠氮复合物的初级光化学反应过程。
Dalton Trans. 2017 Jul 25;46(29):9440-9450. doi: 10.1039/c7dt01529a.
4
To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.该关起来还是被关起来?基于钌的光活化化疗中的细胞毒性物质并不总是金属。
Chem Commun (Camb). 2017 Jun 20;53(50):6768-6771. doi: 10.1039/c7cc03469e.
5
Studies of Carbon Monoxide Release from Ruthenium(II) Bipyridine Carbonyl Complexes upon UV-Light Exposure.光照下钌(II)联吡啶羰基配合物释放一氧化碳的研究。
Inorg Chem. 2017 May 15;56(10):5941-5952. doi: 10.1021/acs.inorgchem.7b00599. Epub 2017 May 3.
6
Chemical Swarming: Depending on Concentration, an Amphiphilic Ruthenium Polypyridyl Complex Induces Cell Death via Two Different Mechanisms.化学集群效应:取决于浓度,一种两亲性钌多吡啶配合物通过两种不同机制诱导细胞死亡。
Chemistry. 2016 Jul 25;22(31):10960-8. doi: 10.1002/chem.201600927. Epub 2016 Jul 4.
7
Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate.反式、反式、反式-[Pt(N₃)₂(OH)₂(py)₂]的综合振动光谱研究,一种铂(IV)二叠氮基抗癌前药候选物。
Inorg Chem. 2016 Jun 20;55(12):5983-92. doi: 10.1021/acs.inorgchem.6b00476. Epub 2016 Jun 3.
8
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物:靶向铂(II)剂、纳米颗粒递送及铂(IV)前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.
9
Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.用于光活化癌症治疗的钌和铑金属配合物激发态的控制与利用
Coord Chem Rev. 2015 Jan 1;282-283:110-126. doi: 10.1016/j.ccr.2014.05.018.
10
Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.羟基喹啉与钌双二甲基菲咯啉支架的配位极大地提高了作为抗肿瘤药物的潜力。
J Med Chem. 2014 Nov 13;57(21):8936-46. doi: 10.1021/jm501043s. Epub 2014 Nov 3.